Masataka Ishimura

Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance

ASL mRNA-LNP Therapeutic for the Treatment of Argininosuccinic Aciduria Enables Survival Benefit in a Mouse Model

Regulatory T cells in autoimmune kidney diseases and transplantation

Suggested guidelines for the diagnosis and management of urea cycle disorders: First revision

Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases

Tregopathies: Monogenic diseases resulting in regulatory T-cell deficiency

On the reversibility of glutamate dehydrogenase and the source of hyperammonemia in the hyperinsulinism/hyperammonemia syndrome

From Krebs to clinic: glutamine metabolism to cancer therapy

Suggested guidelines for the diagnosis and management of urea cycle disorders

High-Affinity, Non-Nucleotide-Derived Competitive Antagonists of Platelet P2Y₁₂Receptors

Regulatory T Cells and Human Disease

Treatment of Epstein Barr virus‐induced haemophagocytic lymphohistiocytosis with rituximab‐containing chemo‐immunotherapeutic regimens

Cytokine Storm

2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host

Anthraquinones As Pharmacological Tools and Drugs

Effects of KP‐496, a novel dual antagonist at the cysteinyl leukotriene receptor 1 and the thromboxane A₂ receptor, on airway obstruction in guinea pigs

Novel exonic mutation inducing aberrant splicing in the IL10RA gene and resulting in infantile-onset inflammatory bowel disease: a case report

Treatment choice of immunotherapy or further chemotherapy for Epstein–Barr virus‐associated hemophagocytic lymphohistiocytosis

Disseminated Bacillus Calmette-Guérin lymphadenitis in a patient with gp91phox − chronic granulomatous disease 25 years after vaccination

A case of hyperinsulinism/hyperammonaemia syndrome with reduced carbamoyl‐phosphate synthetase‐1 activity in liver: A pitfall in enzymatic diagnosis for hyperammonaemia